Coming soon
News
Optellum AI Shown to be Highly Cost-Effective in First US Lifetime Payer Study of Lung Nodule Risk Stratification
First lifetime payer-perspective economic analysis of AI-assisted risk stratification for indeterminate pulmonary nodules (IPN).
Read more

November 12, 2016 / Clinical & Regulatory, Partnerships
‘Dr Computer’ aids intelligent lung cancer diagnosesHealthcare in Europe covered the launch of the LUCINDA project funded by EIT Health and the beginning of Optellum's work. This includes an interview...
Redefining early intervention of lung disease
starting with one of the deadliest, lung cancer
Book your demo
Optellum is trusted by industry & academic leaders




































Certification





Redefining early intervention of lung disease
starting with one of the deadliest, lung cancer
Contact us